J.P. Morgan Private Wealth Advisors LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$208,400
-21.3%
10,000
-9.6%
0.00%0.0%
Q2 2023$264,839
-3.0%
11,058
-23.8%
0.00%0.0%
Q1 2023$272,946
+13.7%
14,503
-3.9%
0.00%0.0%
Q4 2022$240,153
-34.2%
15,085
-3.5%
0.00%0.0%
Q4 2021$365,000
+31.3%
15,628
-6.7%
0.00%0.0%
Q3 2021$278,000
-32.2%
16,743
-0.4%
0.00%0.0%
Q2 2021$410,000
-13.9%
16,804
-8.9%
0.00%
-50.0%
Q1 2021$476,000
-9.0%
18,445
+88.4%
0.00%0.0%
Q4 2020$523,000
+32.7%
9,790
+2.4%
0.00%0.0%
Q3 2020$394,000
-3.7%
9,562
+13.3%
0.00%0.0%
Q2 2020$409,000
+15.2%
8,436
+0.5%
0.00%0.0%
Q1 2020$355,000
+34.0%
8,397
+9.0%
0.00%0.0%
Q1 2017$265,000
-15.9%
7,703
-22.2%
0.00%
-33.3%
Q3 2016$315,000
+29.1%
9,901
+31.5%
0.00%
+50.0%
Q2 2016$244,000
+3.8%
7,531
-10.0%
0.00%0.0%
Q1 2016$235,0008,3680.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 25,819,768$972,631,0007.89%
SECTORAL ASSET MANAGEMENT INC 822,392$30,980,0003.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 240,773$9,068,0003.53%
HARVEY CAPITAL MANAGEMENT INC 230,700$8,690,0003.51%
Palo Alto Investors LP 1,641,030$61,818,0002.60%
GARRISON BRADFORD & ASSOCIATES INC 73,350$2,763,0002.31%
EMORY UNIVERSITY 52,977$1,996,0001.58%
Sivik Global Healthcare LLC 120,000$4,520,0001.54%
Stanley-Laman Group, Ltd. 143,876$5,420,0001.45%
ACUTA CAPITAL PARTNERS, LLC 170,000$6,404,0001.15%
View complete list of ACADIA PHARMACEUTICALS INC shareholders